The Grading and Prevalence of Macular Degeneration in Chesapeake Bay Watermen
about
Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degenerationAntioxidant vitamin and mineral supplements for slowing the progression of age-related macular degenerationCurrent concepts and recent advances in the management of age-related macular degeneration.Antioxidant vitamin and mineral supplements for age-related macular degeneration.New treatments in age-related macular degeneration.Age-related macular degeneration. Can we stem this worldwide public health crisis?Macular degeneration: recent advances and therapeutic opportunities.Reproducibility of gradings of retinal photographs in eyes with subfoveal choroidal neovascularization and age-related macular degeneration in the macular photocoagulation study.Risk factors for age-related maculopathyThe prevalence and analysis of risk factors for age-related macular degeneration: 18-year follow-up data from the Speedwell eye study, United Kingdom.Age-related maculopathy. I: A review of its morphology and effects on visual function.Limited macular translocation.Emerging roles for nuclear receptors in the pathogenesis of age-related macular degeneration.A comparison of some organizational characteristics of the mouse central retina and the human maculaDrusen prevalence and pigmentary changes in Caucasians aged 18-54 years.Application of encapsulated cell technology for retinal degenerative diseases.Quantitative image analysis of macular drusen from fundus photographs and scanning laser ophthalmoscope images.Photography of the anterior eye segment according to Scheimpflug's principle: options and limitations - a review.Prevalence of age-related macular degeneration in an elderly UK Caucasian population-The Bridlington Eye Assessment Project: a cross-sectional study.Age-related macular degeneration among the Inuit in Greenland.Pathogenesis of macular degeneration: is there any progress?Are low inflammatory reactions involved in exudative age-related macular degeneration? Morphological and immunhistochemical analysis of AMD associated with basal deposits.Blue-light filtering alters angiogenic signaling in human retinal pigmented epithelial cells culture model.An evaluation of photographic screening for neovascular age-related macular degeneration.The coexistence of age-related macular degeneration and retinitis pigmentosa in three unrelated families.[Analysis of cardiovascular diseases after the upload phase with intravitreal ranibizumab and bevacizumab in patients with exudative age-related macular degeneration].[Age-related macular degeneration: a socioeconomic time bomb in our aging society].Hormone Replacement Therapy, Reproductive Factors, and Age-Related Macular Degeneration: The Salisbury Eye Evaluation ProjectAn investigation of handheld device use by older adults with age-related macular degenerationY402H-Polymorphismus im Komplementfaktor H und altersabhängige Makuladegeneration (AMD)
P2860
Q24202824-F1173FC0-EA4C-4E9F-917C-AD971E0A4250Q24246241-FE8B295E-0864-4305-8D21-8E310DE7C96EQ30759391-7E21947C-9B6A-4F4E-AE49-D0451105B82FQ30820588-EC412BA5-3D25-47D5-8D1B-8F924D7079F2Q31004243-BB718471-2ECF-488D-8761-EBD03AFADD5CQ32063590-8687178E-523D-4DF5-833C-462AD1EEB7AFQ33260025-7D7EF4E6-195E-4703-81A1-9F4ED5DD6523Q33345456-67C0E6AE-A015-4401-8B13-9F50B2A1089FQ33720834-7EDCD20F-423C-422A-9671-814076CDB178Q33855388-929C64E4-18B0-4CB4-B32C-D1A3D8FAF1E9Q34037389-0B4FF30B-AD7E-4895-9B84-DBF3F9694CE4Q34307055-E0E64449-F694-48D9-9B8E-0FE41BCF70CCQ34518507-5746E62B-58D6-4CB6-9D75-E05AE8C0839AQ35553055-79D2DB66-95D0-4FE5-B03A-7B004F2641FBQ36313773-DD856D23-07CE-46F4-957C-86903345FDC7Q36521847-062C72FF-CB9C-4971-AEE9-A335A1521F9DQ36699811-515B3BC1-F897-44FD-B1AC-55EE6A0BF827Q37429163-15AE8CD5-C2B8-4321-BC13-32326730DBC5Q38915036-72F632FC-F43C-4E52-870E-4B174C8F3E06Q40442199-CA4A4C3A-CB5C-48F8-AAA6-034BE7819206Q41730367-8F4048F6-8F1F-4339-B90E-579BAD8BF37CQ42434913-0DED4558-3F74-4989-826E-95FA1F35EF86Q44744673-B20AC076-F2AA-45A9-80FB-E9E73E42A33BQ44927518-8AD4B1BE-C6F8-4FA6-A3F1-9D9DD5E9A90AQ46044322-F2D246C4-855B-4CD2-8D4D-0E1CC1C9D1DEQ48747309-39BE1352-46BB-4907-AA69-1F4888F016B4Q50787658-B74E5A41-6D26-41C9-A29D-F3E180A112D8Q56831158-BFEEA3A5-1BF2-4673-A14C-BFAF2AFCDAB8Q56893737-9A9DF416-4269-4A89-AC6C-464BD10F3F48Q57655414-CAFF4BBC-6869-4308-98B2-7DCCD6EE52D4
P2860
The Grading and Prevalence of Macular Degeneration in Chesapeake Bay Watermen
description
im Juni 1989 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 01 June 1989
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в червні 1989
@uk
name
The Grading and Prevalence of Macular Degeneration in Chesapeake Bay Watermen
@en
The Grading and Prevalence of Macular Degeneration in Chesapeake Bay Watermen
@nl
type
label
The Grading and Prevalence of Macular Degeneration in Chesapeake Bay Watermen
@en
The Grading and Prevalence of Macular Degeneration in Chesapeake Bay Watermen
@nl
prefLabel
The Grading and Prevalence of Macular Degeneration in Chesapeake Bay Watermen
@en
The Grading and Prevalence of Macular Degeneration in Chesapeake Bay Watermen
@nl
P2093
P1433
P1476
The grading and prevalence of macular degeneration in Chesapeake Bay watermen
@en
P2093
N M Bressler
S B Bressler
P304
P356
10.1001/ARCHOPHT.1989.01070010869032
P407
P577
1989-06-01T00:00:00Z